Trial Profile
The retrospective study as the 1st-line chemotherapy of fluorouracil and bevacizumab for the frail-patients with unresectable or metastatic colorectal cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2013
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Gimeracil/oteracil/tegafur
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 10 Jan 2013 According to the University Hospital Medical Information Network - Japan record the results have been partially published.
- 10 Jan 2013 New trial record